Formulations of anthraquinone derivatives

Details for Australian Patent Application No. 2004271786 (hide)

Owner BTG International Limited

Inventors Ford, Steven John; Elliott, Moira Alexandra; Halbert, Gavin William

Agent Watermark

Pub. Number AU-A-2004271786

PCT Pub. Number WO2005/025537

Priority 0321787.4 17.09.03 GB; 0329875.9 23.12.03 GB

Filing date 16 September 2004

Wipo publication date 24 March 2005

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

C07C 225/30 (2006.01) Compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly-bound oxygen atoms not being part of a CHO group, e.g. amino ketones

Event Publications

6 April 2006 PCT application entered the National Phase

  PCT publication WO2005/025537 Priority application(s): WO2005/025537

8 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004271796-Combination comprising an alpha2-delta ligand and an SSRI and/or SNRI for treatment of depression and anxiety disorders

2004271783-Dry powder composition comprising a benzodiazepine for pulmonary inhalation